Drug Type CAR-T |
Synonyms Allogeneic GCC-CAR-T cell(Wondercel Biotech), REVO-UWD-01, WD-01 |
Target |
Action modulators |
Mechanism GC-C modulators(Heat-stable enterotoxin receptor modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseSuspendedEarly Phase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Colorectal Adenocarcinoma | Phase 1 | China | 23 Oct 2024 | |
| Metastatic Colorectal Carcinoma | Phase 1 | China | 23 Oct 2024 |





